The surgeries in drug-resistant ulcerative colitis are determined by complex factors. This study evaluated the predictive performance of radiomics analysis on the basis of whether patients with ulcerative colitis in hospital were in the surgical or medical treatment group by discharge from hospital. This single-center retrospective cohort study used CT at admission of patients with US admitted from 2015 to 2022. The target of prediction was whether the patient would undergo surgery by the time of discharge. Radiomics features were extracted using the rectal wall at the level of the tailbone tip of the CT as the region of interest. CT data were randomly classified into a training cohort and a validation cohort, and LASSO regression was performed using the training cohort to create a formula for calculating the radiomics score. A total of 147 patients were selected, and data from 184 CT scans were collected. Data from 157 CT scans matched the selection criteria and were included. Five features were used for the radiomics score. Univariate logistic regression analysis of clinical information detected a significant influence of severity (p < 0.001), number of drugs used until surgery (p < 0.001), Lichtiger score (p = 0.024), and hemoglobin (p = 0.010). Using a nomogram combining these items, we found that the discriminatory power in the surgery and medical treatment groups was AUC 0.822 (95% confidence interval (CI) 0.841-0.951) for the training cohort and AUC 0.868 (95% CI 0.729-1.000) for the validation cohort, indicating a good ability to discriminate the outcomes. Radiomics analysis of CT images of patients with US at the time of admission, combined with clinical data, showed high predictive ability regarding a treatment strategy of surgery or medical treatment.

This study aims to create a reliable framework for grading esophageal cancer. The framework combines feature extraction, deep learning with attention mechanisms, and radiomics to ensure accuracy, interpretability, and practical use in tumor analysis. This retrospective study used data from 2,560 esophageal cancer patients across multiple clinical centers, collected from 2018 to 2023. The dataset included CT scan images and clinical information, representing a variety of cancer grades and types. Standardized CT imaging protocols were followed, and experienced radiologists manually segmented the tumor regions. Only high-quality data were used in the study. A total of 215 radiomic features were extracted using the SERA platform. The study used two deep learning models-DenseNet121 and EfficientNet-B0-enhanced with attention mechanisms to improve accuracy. A combined classification approach used both radiomic and deep learning features, and machine learning models like Random Forest, XGBoost, and CatBoost were applied. These models were validated with strict training and testing procedures to ensure effective cancer grading. This study analyzed the reliability and performance of radiomic and deep learning features for grading esophageal cancer. Radiomic features were classified into four reliability levels based on their ICC (Intraclass Correlation) values. Most of the features had excellent (ICC > 0.90) or good (0.75 < ICC ≤ 0.90) reliability. Deep learning features extracted from DenseNet121 and EfficientNet-B0 were also categorized, and some of them showed poor reliability. The machine learning models, including XGBoost and CatBoost, were tested for their ability to grade cancer. XGBoost with Recursive Feature Elimination (RFE) gave the best results for radiomic features, with an AUC (Area Under the Curve) of 91.36%. For deep learning features, XGBoost with Principal Component Analysis (PCA) gave the best results using DenseNet121, while CatBoost with RFE performed best with EfficientNet-B0, achieving an AUC of 94.20%. Combining radiomic and deep features led to significant improvements, with XGBoost achieving the highest AUC of 96.70%, accuracy of 96.71%, and sensitivity of 95.44%. The combination of both DenseNet121 and EfficientNet-B0 models in ensemble models achieved the best overall performance, with an AUC of 95.14% and accuracy of 94.88%. This study improves esophageal cancer grading by combining radiomics and deep learning. It enhances diagnostic accuracy, reproducibility, and interpretability, while also helping in personalized treatment planning through better tumor characterization. Not applicable.

This study aimed to validate the agreement and diagnostic performance of a deep-learning-based coronary artery calcium scoring (DL-CACS) system for ECG-gated and non-gated low-dose chest CT (LDCT) across multivendor datasets. In this retrospective study, datasets from Seoul National University Hospital (SNUH, 652 paired ECG-gated and non-gated CT scans) and the Stanford public dataset (425 ECG-gated and 199 non-gated CT scans) were analyzed. Agreement metrics included intraclass correlation coefficient (ICC), coefficient of determination (R²), and categorical agreement (κ). Diagnostic performance was assessed using categorical accuracy and the area under the receiver operating characteristic curve (AUROC). DL-CACS demonstrated excellent performance for ECG-gated CT in both datasets (SNUH: R² = 0.995, ICC = 0.997, κ = 0.97, AUROC = 0.99; Stanford: R² = 0.989, ICC = 0.990, κ = 0.97, AUROC = 0.99). For non-gated CT using manual LDCT CAC scores as a reference, performance was similarly high (R² = 0.988, ICC = 0.994, κ = 0.96, AUROC = 0.98-0.99). When using ECG-gated CT scores as the reference, performance for non-gated CT was slightly lower but remained robust (SNUH: R² = 0.948, ICC = 0.968, κ = 0.88, AUROC = 0.98-0.99; Stanford: R² = 0.949, ICC = 0.948, κ = 0.71, AUROC = 0.89-0.98). DL-CACS provides a reliable and automated solution for CACS, potentially reducing workload while maintaining robust performance in both ECG-gated and non-gated CT settings. Question How accurate and reliable is deep-learning-based coronary artery calcium scoring (DL-CACS) in ECG-gated CT and non-gated low-dose chest CT (LDCT) across multivendor datasets? Findings DL-CACS showed near-perfect performance for ECG-gated CT. For non-gated LDCT, performance was excellent using manual scores as the reference and lower but reliable when using ECG-gated CT scores. Clinical relevance DL-CACS provides a reliable and automated solution for CACS, potentially reducing workload and improving diagnostic workflow. It supports cardiovascular risk stratification and broader clinical adoption, especially in settings where ECG-gated CT is unavailable.

Lung cancer is the leading cause of patient mortality in the world. Early diagnosis of malignant pulmonary nodules in CT images can have a significant impact on reducing disease mortality and morbidity. In this work, we propose LMLCC-Net, a novel deep learning framework for classifying nodules from CT scan images using a 3D CNN, considering Hounsfield Unit (HU)-based intensity filtering. Benign and malignant nodules have significant differences in their intensity profile of HU, which was not exploited in the literature. Our method considers the intensity pattern as well as the texture for the prediction of malignancies. LMLCC-Net extracts features from multiple branches that each use a separate learnable HU-based intensity filtering stage. Various combinations of branches and learnable ranges of filters were explored to finally produce the best-performing model. In addition, we propose a semi-supervised learning scheme for labeling ambiguous cases and also developed a lightweight model to classify the nodules. The experimental evaluations are carried out on the LUNA16 dataset. Our proposed method achieves a classification accuracy (ACC) of 91.96%, a sensitivity (SEN) of 92.04%, and an area under the curve (AUC) of 91.87%, showing improved performance compared to existing methods. The proposed method can have a significant impact in helping radiologists in the classification of pulmonary nodules and improving patient care.

Lung cancer is the leading cause of cancer-related mortality worldwide. Early lung cancer detection improves lung cancer-related mortality and survival. This report summarizes presentations and panel discussions from a webinar, "The Present and Future of Lung Cancer Screening: Latest Evidence and AI Perspectives." The webinar provided the perspectives of experts from the United States, United Kingdom, and China on evidence-based recommendations and management in lung cancer screening (LCS), barriers, and the role of artificial intelligence (AI). With several countries now incorporating the utilization of AI in their screening programs, AI offers potential solutions to some of the challenges associated with LCS.

Breast cancer is the most frequently diagnosed human cancer in the United States at present. Early detection is crucial for its successful treatment. X-ray mammography and digital breast tomosynthesis are currently the main methods for breast cancer screening. However, both have known limitations in terms of their sensitivity and specificity to breast cancers, while also frequently causing patient discomfort due to the requirement for breast compression. Breast computed tomography is a promising alternative, however, to obtain high-quality images, the X-ray dose needs to be sufficiently high. As the breast is highly radiosensitive, dose reduction is particularly important. Phase-contrast computed tomography (PCT) has been shown to produce higher-quality images at lower doses and has no need for breast compression. It is demonstrated in the present study that, when imaging full fresh mastectomy samples with PCT, deep learning-based image denoising can further reduce the radiation dose by a factor of 16 or more, without any loss of image quality. The image quality has been assessed both in terms of objective metrics, such as spatial resolution and contrast-to-noise ratio, as well as in an observer study by experienced medical imaging specialists and radiologists. This work was carried out in preparation for live patient PCT breast cancer imaging, initially at specialized synchrotron facilities.

The distribution of visceral adipose tissue (VAT) in cystectomy patients is indicative of the incidence of postoperative complications. Existing VAT segmentation methods for computed tomography (CT) employing intensity thresholding have limitations relating to inter-observer variability. Moreover, the difficulty in creating ground-truth masks limits the development of deep learning (DL) models for this task. This paper introduces a novel method for VAT prediction in pre-cystectomy CT, which is fully automated and does not require ground-truth VAT masks for training, overcoming aforementioned limitations. We introduce the kernel density-enhanced VAT segmentator (KEVS), combining a DL semantic segmentation model, for multi-body feature prediction, with Gaussian kernel density estimation analysis of predicted subcutaneous adipose tissue to achieve accurate scan-specific predictions of VAT in the abdominal cavity. Uniquely for a DL pipeline, KEVS does not require ground-truth VAT masks. We verify the ability of KEVS to accurately segment abdominal organs in unseen CT data and compare KEVS VAT segmentation predictions to existing state-of-the-art (SOTA) approaches in a dataset of 20 pre-cystectomy CT scans, collected from University College London Hospital (UCLH-Cyst), with expert ground-truth annotations. KEVS presents a <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>4.80</mn> <mo>%</mo></mrow> </math> and <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>6.02</mn> <mo>%</mo></mrow> </math> improvement in Dice coefficient over the second best DL and thresholding-based VAT segmentation techniques respectively when evaluated on UCLH-Cyst. This research introduces KEVS, an automated, SOTA method for the prediction of VAT in pre-cystectomy CT which eliminates inter-observer variability and is trained entirely on open-source CT datasets which do not contain ground-truth VAT masks.

Retroperitoneal sarcoma (RPS) is highly heterogeneous, leading to different risks of distant metastasis (DM) among patients with the same clinical stage. This study aims to develop a quantitative method for assessing intratumoral heterogeneity (ITH) using preoperative contrast-enhanced CT (CECT) scans and evaluate its ability to predict DM risk. We conducted a retrospective analysis of 274 PRS patients who underwent complete surgical resection and were monitored for ≥ 36 months at two centers. Conventional radiomics (C-radiomics), ITH radiomics, and deep-learning (DL) features were extracted from the preoperative CECT scans and developed single-modality models. Clinical indicators and high-throughput CECT features were integrated to develop a combined model for predicting DM. The performance of the models was evaluated by measuring the receiver operating characteristic curve and Harrell's concordance index (C-index). Distant metastasis-free survival (DMFS) was also predicted to further assess survival benefits. The ITH model demonstrated satisfactory predictive capability for DM in internal and external validation cohorts (AUC: 0.735, 0.765; C-index: 0.691, 0.729). The combined model that combined clinicoradiological variables, ITH-score, and DL-score achieved the best predictive performance in internal and external validation cohorts (AUC: 0.864, 0.801; C-index: 0.770, 0.752), successfully stratified patients into high- and low-risk groups for DM (p < 0.05). The combined model demonstrated promising potential for accurately predicting the DM risk and stratifying the DMFS risk in RPS patients undergoing complete surgical resection, providing a valuable tool for guiding treatment decisions and follow-up strategies. The intratumoral heterogeneity analysis facilitates the identification of high-risk retroperitoneal sarcoma patients prone to distant metastasis and poor prognoses, enabling the selection of candidates for more aggressive surgical and post-surgical interventions. Preoperative identification of retroperitoneal sarcoma (RPS) with a high potential for distant metastasis (DM) is crucial for targeted interventional strategies. Quantitative assessment of intratumoral heterogeneity achieved reasonable performance for predicting DM. The integrated model combining clinicoradiological variables, ITH radiomics, and deep-learning features effectively predicted distant metastasis-free survival.

This study aimed to investigate the performance of an artificial intelligence (AI)-based lung nodule detection program in ultra-low-dose CT (ULDCT) imaging, with a focus on the influence of various image reconstruction methods on detection accuracy. A chest phantom embedded with artificial lung nodules (solid and ground-glass nodules [GGNs]; diameters: 12 mm, 8 mm, 5 mm, and 3 mm) was scanned using six combinations of tube currents (160 mA, 80 mA, and 10 mA) and voltages (120 kV and 80 kV) on a Canon Aquilion One CT scanner. Images were reconstructed using filtered back projection (FBP), hybrid iterative reconstruction (HIR), model-based iterative reconstruction (MBIR), and deep learning reconstruction (DLR). Nodule detection was performed using an AI-based lung nodule detection program, and performance metrics were analyzed across different reconstruction methods and radiation dose protocols. At the lowest dose protocol (80 kV, 10 mA), FBP showed a 0% detection rate for all nodule sizes. HIR and DLR consistently achieved 100% detection rates for solid nodules ≥ 5 mm and GGNs ≥ 8 mm. No method detected 3 mm GGNs under any protocol. DLR demonstrated the highest detection rates, even under ultra-low-dose settings, while maintaining high image quality. AI-based lung nodule detection in ULDCT is strongly dependent on the choice of image reconstruction method.

Artificial intelligence (AI) promises to compress stroke treatment timelines, yet its clinical return on investment remains uncertain. We interrogate state‑of‑the‑art AI platforms across imaging, workflow orchestration, and outcome prediction to clarify value drivers and execution risks. Convolutional, recurrent, and transformer architectures now trigger large‑vessel‑occlusion alerts, delineate ischemic core in seconds, and forecast 90‑day function. Commercial deployments-RapidAI, Viz.ai, Aidoc-report double‑digit reductions in door‑to‑needle metrics and expanded thrombectomy eligibility. However, dataset bias, opaque reasoning, and limited external validation constrain scalability. Hybrid image‑plus‑clinical models elevate predictive accuracy but intensify data‑governance demands. AI can operationalize precision stroke care, but enterprise‑grade adoption requires federated data pipelines, explainable‑AI dashboards, and fit‑for‑purpose regulation. Prospective multicenter trials and continuous lifecycle surveillance are mandatory to convert algorithmic promise into reproducible, equitable patient benefit.